INVEGA SUSTENNA PALIPERIDONE 75MG/ML INJECTION – 1

Invega Sustenna (paliperidone palmitate) is an injectable antipsychotic medication primarily used for the treatment of schizophrenia and schizoaffective disorder in adults. It is a long-acting formulation that allows for once-monthly administration, which can improve adherence to treatment compared to daily oral medications.

Invega Sustenna works by modulating the effects of neurotransmitters in the brain, particularly dopamine and serotonin, which are believed to play a key role in mood and behavior regulation.

The 75 mg/ml injection is typically administered intramuscularly, and the dosage may vary based on individual patient needs and response to treatment.

In addition to its primary uses, Invega Sustenna may also be utilized off-label for other psychiatric conditions, but its main indication remains the management of schizophrenia and schizoaffective disorder, helping to reduce symptoms such as hallucinations, delusions, and disorganized thinking.